• Nem Talált Eredményt

Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University of Pécs and at the University of Debrecen

N/A
N/A
Protected

Academic year: 2022

Ossza meg "Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s Programmes at the University of Pécs and at the University of Debrecen"

Copied!
19
0
0

Teljes szövegt

(1)

in the Teaching Material of

Medical Biotechnology Master’s Programmes

at the University of Pécs and at the University of Debrecen

Identification number: TÁMOP-4.1.2-08/1/A-2009-0011

(2)

ADAPTATION AND VULNERABILITY, POLYMORBIDITY

Miklós Székely and Márta Balaskó

Molecular and Clinical Basics of Gerontology – Lecture 2

Medical Biotechnology Master’s Programmes

at the University of Pécs and at the University of Debrecen

Identification number: TÁMOP-4.1.2-08/1/A-2009-0011

(3)

Asthma

Renal disease Diabetes

Cardiac disease Arthritis

Cancer

Correlation of

morbidity rates and age

Morbidity rate

• increase peaks

at 60y,

• decelerates after 80y,

• remains linear after 110y

0 20 40 60 80 100

10 30 50

0 20 40 60

% with disease

Age (years)

Sinusitis

(4)

Fat, fat-free mass and cell mass of males and females at various ages

Fat , fat-free mass, and cell mass of males () and females () at

various ages, values are given, and the number of subjects in each age group is noted.

27 58 33

37

42

18

89 33 44

72 54 13

18–25 25–35 35–45 45–55 55–65 65–85

Age (years)

Absolute weight (kg)

10 20 30 40 50 60

(5)

Age-related changes in different functions

Age (years)

Hypothetic function (%)

20 100

50

0 30 40 50 60 70 80 90

(6)

Average age differences in physiological functions among normal male subjects

Basal metabolic rate

Standard glomerular filtration rate (inulin)

Standard renal plasma flow (diodrast)

Maximal breathing capacity

Vital capacity

Standard renal plasma flow (PAH)

Conduction velocity

Cardiac index

Standard cell water

30 40 50 60 70

20 7 0

50

0 30 40 60

Percent property remaining (average)

Age (years)

80 90 8

0 9 0 100

(7)

Effect of 50 mmHg increment in

systolic blood pressure on heart rate,

cardiac index and stroke index in young and old rats

Percent Change

Young Old 50

10

-40 40 30 20

0 -10 -20 -30

Heart rate Cardiac index Stroke index

< .001 ≤ .05 NS

NS NS

≤ .05

≤ .001

<

.001

<

.001

(8)

ADH effect decreases with age

U/P inulin (urine/plasma conc. ratio)

Urine Collection Period

0 0 10 20 30 40 50 60 70 80 90 100 110 120

1 2 3 4 5 6 7 8 9 10

Young Middle Old

ADH

(9)

Glucose tolerance tests*

in different age-groups

Time (min)

Blood sugar (mM)

0 5 6 7 8 9 10 11 12

20 30

40 50 60

70

Age (years)

0 20

60 90 120 150

* 50 g glucose p.o.

(10)

Organ capacity

Healthy (old)

Functional capacity of an organ

Healthy (young)

Sick

(young or old) Essential

functional minimum Reserve capacity

(11)

Plasma epinephrine and

norepinephrine vs. age during work

Age (years)

0 20 30 40 50 60 70 80 0

400 800 1200 1600 2000

Plasma Norepinephrine (pg/ml)

Age (years)

0 20 30 40 50 60 70 80 0

50 100 150 200 250

Plasma Epinephrine (pg/ml)

0% grade 3% grade 9% grade 6% grade

Resting

(12)

Characteristics of aging

Decreased performance and compensation capacity

• Sensitive balance among the failing organ systems

• Interactions: It is always the weakest link that would cause symptoms (not what the original disease is!)

• “Monotonous”, atypical symptoms: organ specific symptoms, functional syndromes instead

(13)

Further characteristics of aging

• Frequent changes in symptoms

• Fewer acute syndromes, with less intensive or striking onset

• Opposed to this, more chronic syndromes that impair the quality of life

• Multimorbidity

• Medication related problems.

Distribution and excretion of drugs change with age.

(14)

Prevalence of multimorbidity

Using 24 major diagnostic categories…

• 82 percent of people aged 65 and older had one or more chronic conditions

• 65 percent had two or more

• 43 percent had three or more

• 24 percent had four or more.

On average there are 2.3

chronic conditions reported by people aged 65 and older.

Wolff JL, Starfield B, Anderson G. Arch Intern Med. 2002;162:2269-2276 0

10 20 30 40 50 60 70 80 90

1 or more 2 or more 3 or more 4 or more

(15)

Characteristics of diseases in the elderly

• Multimorbidity

• The number of chronic incurable diseases increases

• Necessary compromises during treatment, determine priorities

• Gradual, hidden start

• A large number of secondary complications (limited capacity to compensate)

• Increased need for rehabilitation

(importance of psychological and social factors)

(16)

Functional syndromes

• Instability, impaired homeostasis

• Immobility, falls

• Intellectual abnormalities (confusion)

• Incontinence

• Iatrogenic disorders

(17)

Incompetence (Confusion)

Geriatric Giants

Immobility

(Falls) Incontinence

Iatrogenic disorders Impaired

homeostasis

(18)

to which the elderly are susceptible because of their medical problems

Illness

Medication

Drug

interaction Drug

adverse effect

(19)

Aims of therapy

• Transition from hospital to (nursing) home

• Relief of e.g. pain

• Improvement in self-care, independence

• Improvement of physical activity and fitness

• Improvement in functional abilities, better quality of life (QOL)

• Complete recovery (?)

Hivatkozások

KAPCSOLÓDÓ DOKUMENTUMOK

development; Drosophila segmentation Nuclear hormone receptors Glucocorticoid receptor, estrogen receptor,. testosterone receptor, retinoic acid receptors Secondary

• EBF: early B-cell factor, B-cell fate determinant, turns on B- cell specific genes. • Pax5: in its absence cells are blocked at pro-B stage, self renew, broad

ZAP-70 is normally expressed in T cells and natural killer cells and has a critical role in the initiation of T-cell signaling. • ZAP-70 in B cells is used as a prognostic marker

• Cytokines: TNF, IL-1, IL-4, IL-5, IL-6, IL-13, MIP-1a, IL-3,

• After ligand binding, the tyrosine (Y) residue of the ITAM is phosphorylated by tyrosine kinases, and a signaling cascade is generated within the cell.. • An ITAM is present in

Cytokine binding dimerizes the receptor, bringing together the cytoplasmic JAKs, which activate each. other and phosphorylate

Member of a family of proteins termed neutrophins that promote proliferation and survival of neurons; neutrophin receptors are a class of related proteins first identified

• Scavenger receptors bind to bacterial cell wall components such as LPS, peptidoglyan and teichoic acids and stressed, infected, or injured cells. Scavenger